Literature DB >> 16011869

Safety assessment on polyethylene glycols (PEGs) and their derivatives as used in cosmetic products.

Claudia Fruijtier-Pölloth1.   

Abstract

This assessment focusses on polyethylene glycols (PEGs) and on anionic or nonionic PEG derivatives, which are currently used in cosmetics in Europe. These compounds are used in a great variety of cosmetic applications because of their solubility and viscosity properties, and because of their low toxicity. The PEGs, their ethers, and their fatty acid esters produce little or no ocular or dermal irritation and have extremely low acute and chronic toxicities. They do not readily penetrate intact skin, and in view of the wide use of preparations containing PEG and PEG derivatives, only few case reports on sensitisation reactions have been published, mainly involving patients with exposure to PEGs in medicines or following exposure to injured or chronically inflamed skin. On healthy skin, the sensitising potential of these compounds appears to be negligible. For some representative substances of this class, information was available on reproductive and developmental toxicity, on genotoxicty and carcinogenic properties. Taking into consideration all available information from related compounds, as well as the mode and mechanism of action, no safety concern with regard to these endpoints could be identified. Based on the available data it is therefore concluded that PEGs of a wide molecular weight range (200 to over 10,000), their ethers (laureths. ceteths, ceteareths, steareths, and oleths), and fatty acid esters (laurates, dilaurates, stearates, distearates) are safe for use in cosmetics. Limited data were available for PEG sorbitan/sorbitol fatty acid esters, PEG sorbitan beeswax and PEG soy sterols. Taking into account all the information available for closely related compounds, it can be assumed that these compounds as presently used in cosmetic preparations will not present a risk for human health. PEG castor oils and PEG hydrogenated castor oils have caused anaphylactic reactions when used in intravenous medicinal products. Their topical use in cosmetics is, however, considered safe as they are not expected to be systemically available. As all PEGs and PEG derivatives, they must not be applied to damaged skin. Manufacturers of PEGs and PEG derivatives must continue their efforts to remove impurities and by-products such as ethylene oxide and 1,4-dioxane. Overall, it is concluded, that the PEGs covered in this review are safe for use in cosmetics under the present conditions of intended use.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16011869     DOI: 10.1016/j.tox.2005.06.001

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  45 in total

1.  Evaluation of topical hesperetin matrix film for back-of-the-eye delivery.

Authors:  Goutham R Adelli; Tushar Hingorani; Nagendra Punyamurthula; Sai Prachetan Balguri; Soumyajit Majumdar
Journal:  Eur J Pharm Biopharm       Date:  2015-02-26       Impact factor: 5.571

2.  The Mystery of Antibodies Against Polyethylene Glycol (PEG) - What do we Know?

Authors:  Christian Lubich; Peter Allacher; Maurus de la Rosa; Alexander Bauer; Thomas Prenninger; Frank Michael Horling; Jürgen Siekmann; Johannes Oldenburg; Friedrich Scheiflinger; Birgit Maria Reipert
Journal:  Pharm Res       Date:  2016-06-07       Impact factor: 4.200

Review 3.  The role of nanotechnology in the treatment of viral infections.

Authors:  Lavanya Singh; Hendrik G Kruger; Glenn E M Maguire; Thavendran Govender; Raveen Parboosing
Journal:  Ther Adv Infect Dis       Date:  2017-07-05

Review 4.  Designing degradable hydrogels for orthogonal control of cell microenvironments.

Authors:  Prathamesh M Kharkar; Kristi L Kiick; April M Kloxin
Journal:  Chem Soc Rev       Date:  2013-04-22       Impact factor: 54.564

Review 5.  Polyethylene glycols: An effective strategy for limiting liver ischemia reperfusion injury.

Authors:  Gianfranco Pasut; Arnau Panisello; Emma Folch-Puy; Alexandre Lopez; Carlos Castro-Benítez; Maria Calvo; Teresa Carbonell; Agustín García-Gil; René Adam; Joan Roselló-Catafau
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

Review 6.  Immunogenicity Risk Assessment for PEGylated Therapeutics.

Authors:  Johanna R Mora; Joleen T White; Stephen L DeWall
Journal:  AAPS J       Date:  2020-01-28       Impact factor: 4.009

7.  Sinonasal tumor in 3 dogs after successful topical treatment for frontal sinus aspergillosis.

Authors:  Valentina Greci; Damiano Stefanello; Mauro Di Giancamillo; Carlo M Mortellaro
Journal:  Can Vet J       Date:  2009-11       Impact factor: 1.008

8.  Synthetic Strategy for Preparing Chiral Double-semicrystalline Polyether Block Copolymers.

Authors:  Alaina J McGrath; Weichao Shi; Christina G Rodriguez; Edward J Kramer; Craig J Hawker; Nathaniel A Lynd
Journal:  Polym Chem       Date:  2015-03-07       Impact factor: 5.582

9.  Biodefunctionalization of functionalized single-walled carbon nanotubes in mice.

Authors:  Sheng-Tao Yang; Haifang Wang; Mohammed J Meziani; Yuanfang Liu; Xin Wang; Ya-Ping Sun
Journal:  Biomacromolecules       Date:  2009-05-08       Impact factor: 6.988

10.  Polyoxyethylene 40 stearate modulates multidrug resistance and enhances antitumor activity of vinblastine sulfate.

Authors:  Lingying Luo; Xiaoqiang Xu; Beijia Shi; Jinhui Wu; Yiqiao Hu
Journal:  AAPS J       Date:  2007-10-05       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.